541299 — Dr Lalchandani Labs Balance Sheet
0.000.00%
- IN₹71.84m
- IN₹79.54m
- IN₹44.54m
- 39
- 51
- 27
- 31
Annual balance sheet for Dr Lalchandani Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | PRESS |
Standards: | IAS | IAS | — |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 31 | 22.9 | 33 |
Net Total Accounts Receivable | |||
Net Total Receivables | 58 | 53.1 | 58.8 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 110 | 94.8 | 109 |
Net Property, Plant And Equipment | 50.3 | 37 | 32.6 |
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 177 | 150 | 157 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 53.2 | 50.3 | 56.6 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Liabilities | 88 | 54.5 | 57.9 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 89.2 | 95.4 | 99.6 |
Total Liabilities & Shareholders' Equity | 177 | 150 | 157 |
Total Common Shares Outstanding |